These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34293856)

  • 21. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
    Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
    Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia.
    Caturla F; Amat M; Reinoso RF; Córdoba M; Warrellow G
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3209-12. PubMed ID: 16616494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors.
    Hilário MO; Terreri MT; Len CA
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S206-12. PubMed ID: 17136297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorophore-labeled cyclooxygenase-2 inhibitors for the imaging of cyclooxygenase-2 overexpression in cancer: synthesis and biological studies.
    Bhardwaj A; Kaur J; Wuest F; Knaus EE
    ChemMedChem; 2014 Jan; 9(1):109-16, 240. PubMed ID: 24376205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
    Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel urea-diarylpyrazole hybrids as dual COX-2/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks.
    Abdelazeem AH; Safi El-Din AG; Abdel-Fattah MM; Amin NH; El-Moghazy SM; El-Saadi MT
    Eur J Med Chem; 2020 Nov; 205():112662. PubMed ID: 32763463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel celecoxib analogues by bioisosteric replacement of sulfonamide as potent anti-inflammatory agents and cyclooxygenase inhibitors.
    Chandna N; Kumar S; Kaushik P; Kaushik D; Roy SK; Gupta GK; Jachak SM; Kapoor JK; Sharma PK
    Bioorg Med Chem; 2013 Aug; 21(15):4581-90. PubMed ID: 23769654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.
    Reddy MV; Billa VK; Pallela VR; Mallireddigari MR; Boominathan R; Gabriel JL; Reddy EP
    Bioorg Med Chem; 2008 Apr; 16(7):3907-16. PubMed ID: 18272371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LLW-3-6 and celecoxib impacts growth in prostate cancer cells and subcellular localization of COX-2.
    Yerokun T; Winfield LL
    Anticancer Res; 2014 Sep; 34(9):4755-9. PubMed ID: 25202054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J; Kumar V; Sobhia ME; Jachak SM
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydropyrazole Derivatives Containing Benzo Oxygen Heterocycle and Sulfonamide Moieties Selectively and Potently Inhibit COX-2: Design, Synthesis, and Anti-Colon Cancer Activity Evaluation.
    Yan XQ; Wang ZC; Zhang B; Qi PF; Li GG; Zhu HL
    Molecules; 2019 Apr; 24(9):. PubMed ID: 31052167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells.
    Wang X; Wang L; Xie L; Xie Z; Li L; Bui D; Yin T; Gao S; Hu M
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors.
    Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib.
    Sobolewski C; Legrand N
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spectroscopic study on the interaction of celecoxib with human carbonic anhydrase II: thermodynamic characterization of the binding process.
    Mehrabi M; Ghobadi S; Khodarahmi R
    J Photochem Photobiol B; 2009 Dec; 97(3):161-8. PubMed ID: 19879770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.